Biperiden

CAS No:
514-65-8 Category:
  • #LGM Pharma is a Biperiden CAS# 514-65-8 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 514-65-8
  • AHFC code: 12:08.0
  • Synonyms: Beperiden Biperiden [Usan:Ban:Inn:Jan] Biperiden Hydrochloride Biperidene [INN-French] Biperidene Hydrochloride Biperideno [INN-Spanish] Biperidenum [INN-Latin] Biperidine Biperidine Hydrochloride
  • ATC Code: N04AA02
  • Chemical Formula: C6H14O6S2
  • Molecular Weight: 311.4611
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB00810 (APRD00725)
  • SMILES: OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1
  • InChl: YSXKPIUOCJLQIE-UHFFFAOYSA-N
  • PubChem: 2381
  • IUPAC: 1-{bicyclo[2.2.1]hept-5-en-2-yl}-1-phenyl-3-(piperidin-1-yl)propan-1-ol

Additional Details

Indication:
For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.
Pharmacodynamics:
Biperiden is a weak peripheral anticholinergic agent. It has, therefore, some antisecretory, antispasmodic and mydriatic effects. In addition, biperiden possesses nicotinolytic activity. The parenteral form of biperiden is an effective and reliable agent for the treatment of acute episodes of extrapyramidal disturbances sometimes seen during treatment with neuroleptic agents. Akathisia, akinesia, dyskinetic tremors, rigor, oculogyric crisis, spasmodic torticollis, and profuse sweating are markedly reduced or eliminated. With parenteral biperiden, these drug-induced disturbances are rapidly brought under control.
Mode of Action:
Parkinsonism is thought to result from an imbalance between the excitatory (cholinergic) and inhibitory (dopaminergic) systems in the corpus striatum. The mechanism of action of centrally active anticholinergic drugs such as biperiden is considered to relate to competitive antagonism of acetylcholine at cholinergic receptors in the corpus striatum, which then restores the balance.
Metabolism:
The metabolism of biperiden is not completely understood, but does involve hydroxylation.
Toxicity:
LD50=760 mg/kg (Orally in rats). Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
General Reference:
Nishiyama K, Mizuno T, Sakuta M, Kurisaki H: Chronic dementia in Parkinsonês disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination. Adv Neurol. 1993;60:479-83. Pubmed
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials

 

Related YouTube Videos